Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEM vs GSK✓SelectedUSD · GSKTEM vs GSK performance historyLatest closeAs of+0.30%11/18
Stock and ETF performance explorer

TEM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+58.1%
GSK return
+31.2%
Excess return
+26.8%
Maximum drawdown
-59.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-1.3%+1.6%+0.8%
7D-19.9%-3.1%-16.8%-19.0%
30D-1.1%-0.9%-0.2%-1.1%
3M+28.9%-4.2%+33.1%+30.8%
6M+45.9%-1.6%+47.4%+45.4%
YTD+7.7%+2.6%+5.1%+3.3%
1Y-4.7%+6.2%-10.9%-10.2%
All+58.1%+31.2%+26.8%+31.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling